Akaike, T., Jabbour, A. J., Goff, P. H., Park, S. Y., Bhatia, S., Nghiem, P.

Merkel cell carcinoma (MCC) incidence has risen to approximately 3,000 cases annually in the USA. Although anti-programmed cell death (ligand) 1 (PD-(L)1) agents are now the first-line treatment for advanced MCC, approximately 50% of such patients do …